Back to Browse Journals » Vascular Health and Risk Management » Volume 5

The management of gestational diabetes

Authors N Wah Cheung

Published Date January 2009 Volume 2009:5 Pages 153—164

DOI http://dx.doi.org/10.2147/VHRM.S3405

Published 15 January 2009

N Wah Cheung

Centre for Diabetes and Endocrinology Research, Westmead Hospital, and University of Sydney, NSW, Australia

Abstract: The incidence of gestational diabetes is increasing. As gestational diabetes is associated with adverse pregnancy outcomes, and has long-term implications for both mother and child, it is important that it is recognized and appropriately managed. This review will examine the pharmacological options for the management of gestational diabetes, as well as the evidence for blood glucose monitoring, dietary and exercise therapy. The medical management of gestational diabetes is still evolving, and recent randomized controlled trials have added considerably to our knowledge in this area. As insulin therapy is effective and safe, it is considered the gold standard of pharmacotherapy for gestational diabetes, against which other treatments have been compared. The current experience is that the short acting insulin analogs lispro and aspart are safe, but there are only limited data to support the use of long acting insulin analogs. There are randomized controlled trials which have demonstrated efficacy of the oral agents glyburide and metformin. Whilst short-term data have not demonstrated adverse effects of glyburide and metformin on the fetus, and they are increasingly being used in pregnancy, there remain long-term concerns regarding their potential for harm.

Keywords: gestational diabetes, insulin, oral antidiabetic agents, pregnancy, type 2 diabetes

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

The relationship between Graves’ ophthalmopathy and dry eye syndrome

Selter JH, Gire AI, Sikder S

Clinical Ophthalmology 2015, 9:57-62

Published Date: 31 December 2014

The evaluation and optimal use of rituximab in lymphoid malignancies

Robak T, Robak P, Smolewski P

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:1-16

Published Date: 4 January 2012

Small coronary vessel angioplasty: outcomes and technical considerations

Sudhir Rathore

Vascular Health and Risk Management 2010, 6:915-922

Published Date: 11 October 2010

Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study

Laura J Gray, Jennifer R Tringham, Melanie J Davies, et al

Vascular Health and Risk Management 2010, 6:837-842

Published Date: 20 September 2010

Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG

Sandra Eifert, Helmut Mair, Anne-Laure Boulesteix, et al

Vascular Health and Risk Management 2010, 6:495-501

Published Date: 29 June 2010

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

Rakesh K Sharma, Vibhuti N Singh, Hanumanth K Reddy

Vascular Health and Risk Management 2009, 5:793-799

Published Date: 21 September 2009

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention

Jesús Millán, Xavier Pintó, Anna Muñoz, et al

Vascular Health and Risk Management 2009, 5:757-765

Published Date: 10 September 2009

Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension

Amber Lundy, Nahla Lutfi, Cherylyn Beckey

Vascular Health and Risk Management 2009, 5:429-440

Published Date: 8 May 2009

Dual factor pulse pressure: body mass index and outcome in type 2 diabetic subjects on maintenance  hemodialysis. A longitudinal study 2003–2006

Lydia Foucan, Kheira Hue, Jocelyn Inamo, Jacqueline Deloumeaux, Anne Blanchet-Deverly, et al

Vascular Health and Risk Management 2008, 4:1401-1406

Published Date: 9 October 2008